Public opinion as questions not answers:

How citizens evaluate the therapeutic

potential of stem cell research in the context

of T1 diabetes by Kotchetkova, Inna et al.
                                                                        
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Public opinion as questions not answers:  
How citizens evaluate the therapeutic 
potential of stem cell research in the context 
of T1 diabetes 
ESRC National Centre for Research Methods 
 
NCRM Working Paper Series 
 
7/07 
 
 
 
Dr Inna Kotchetkova, Cardiff University 
Dr Robert Evans, Cardiff University 
Dr Susanne Langer, University of Manchester 
 
 
 
Working Paper 
 
Public opinion as questions not answers: how citizens 
evaluate the therapeutic potential of stem cell 
research in the context of T1 diabetes 
 
Dr Inna Kotchetkova, Cardiff University 
Dr Robert Evans, Cardiff University 
Dr Susanne Langer, University of Manchester 
March 2007 
 
 
 
 
 
 
 
Qualiti, School of Social Sciences, Cardiff University, Cardiff, CF10 3WT 
+44(0) 29 2087 5345 
qualiti@cardiff.ac.uk 
www.cardiff.ac.uk/socsi/qualiti  
Qualiti Working Papers: Public Opinion as questions not answers: how citizens evaluate the therapeutic 
potential of stem cell research in the context of T1 diabetes  
March 2007 2 
Author contact details 
 
Dr Inna Kotchetkova 
Qualiti (a node of the ESRC National Centre for Research Methods) 
Cardiff School of Social Sciences 
Cardiff University 
Glamorgan Building 
King Edward VII Avenue 
Cardiff 
Wales 
CF10 3WT 
 
kotchetkovai@cardiff.ac.uk
Qualiti Working Papers: Public Opinion as questions not answers: how citizens evaluate the therapeutic 
potential of stem cell research in the context of T1 diabetes  
March 2007 3 
 ‘… there is nothing a government hates more than to be well-informed; for it 
makes the process of arriving at decisions much more complicated and difficult’ 
(John Maynard Keynes, quoted in Skidelsky, R.,1992: 630)  
 
Public participation in science and technology  
It is now commonplace for policy-makers, think-tanks and social scientists to call 
for increased public participation in science and technology policy (e.g. House of 
Lords, 2000; Wilsden and Willis, 2004; CST, 2005). Nowhere is this more 
apparent than in stem cell science. The recent Pattison report1 on the UK Stem 
Cell Initiative called on the government to invest at least £350m in stem cell 
research by 2016 and also stressed the importance of maintaining a ‘close liaison 
of parties involved in developing regulation and public dialogue on stem cell 
research’ (recommendations 8 & 11). Whilst laudable, the idea of increased 
participation is not without its problems. For example, one frequently expressed 
concern is that public dialogue comes too late in the process to effect any 
significant change. From this perspective, consultation exercises are seen as 
ways of re-building trust so that what is presented as an exercise in democratic 
participation can often be interpreted as an investigation into how to gain support 
of the public (cf Irwin, 2001, 2006; Rayner, 2003; Rowe and Frewer, 2004). 
 
Understanding and representing public opinion is, therefore becoming an 
increasingly important part of scientific innovation in potentially controversial 
areas like stem cell research.2 As such, it is not surprising that research exploring 
the determinants of public attitudes has become a key part of the social science 
contribution to the biosciences (e.g. Evans and Durant, 1995; Durant and Legge, 
2005). It is also unsurprising that, when evidence of public support or opposition 
is uncovered it is used by campaigners to bolster their particular case. A typical 
example of this is the reporting of the GM Nation Debate in the UK which, to the 
dismay of many scientists, was typically presented as having proved that the 
majority of the British public were opposed to GM crops. 
 
In this paper, we focus on public opinions about stem cell research and argue 
that it is misleading to talk about public attitudes to uncertain and controversial 
scientific research in terms of binary oppositions of support and resistance. 
Instead, we examine attitudes to stem cell research in a more contextual way, 
exploring how different groups – patients, carers and lay citizens – locate stem 
cell research in relation to other existing and potential therapeutic pathways.3 The 
study revealed that participants’ attitudes to stem cell research were ambivalent 
rather than certain and that, whilst in no  way were our participants fundamentally 
opposed to stem cell research, cautious and critical voices were prominent in all 
discussions.  
 
Drawing on data from a series of focus groups, we show that participants did not 
rank stem cell research particularly highly when it was presented as one of 
several options. We also show that, within the focus groups, different kinds of 
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participants tended to use different arguments in discounting the importance of 
stem cell research. Significantly, none of these groups found that the ‘ethical 
issues’ which dominate the media debate to be particularly important. In 
examining how different values and priorities were placed on stem cell research, 
our research demonstrates that more complex mechanisms are needed to 
adequately reflect ‘public attitudes to stem cell research’ and , by extension, other 
similar areas such as nanotechnology. In the remainder of the paper we describe 
our research design and our findings in more detail. We begin, however, by 
scrutinizing the most popular measure of public opinion – the opinion poll – 
before considering the alternative, qualitative approach used in our own 
research. 
Public engagement in stem cell research 
It is possible to argue that the ‘liaison’ called for in the Pattison Report has 
already begun. Several public dialogue activities about stem cell research, 
ranging from citizens’ juries, public consultations and opinion polls, have already 
been completed in the UK.4 It is significant, however, that it is only the results of 
an opinion poll conducted by MORI (MORI 2003), which found that the ‘majority 
(70%) of the members of the British public support the use of embryos for 
medical research,’ that appear to have been noted in Government policy. 5 
 
As most social scientists know only too well, the apparent objectivity of surveys is 
as much a matter of their presentation as their methods. For example, although 
the claim that ‘The vast majority of the UK public currently supports the use of 
embryonic stem cells in medical research’ (Pattison report, p.26) is widely 
reported, this has a very different effect to saying that nearly 1 in 3 citizens do not 
support the use of embryonic stem cells in medical research. Similarly, the 
Pattison Report does not mention that the same MORI poll found that only ‘one in 
six members of British public feel the use of human embryos is always 
acceptable for all types of medical research’.6  
 
Determined critics of the research can, and do, go further. In addition to the 
obvious claim that the poll itself was commissioned by a coalition of public sector 
and charitable organisations involved in medical research, they can also 
challenge the ability of respondents to make the judgements required by the 
survey. A poll commissioned 2 years later (2005) by newspaper The Daily 
Telegraph found that 60% of those surveyed said they did not feel well enough 
informed about the relevant science to make decisions about topics such as 
cloning and stem-cell research.7 More generally, it has been shown that question 
wording has a significant influence on the results, with this effect particularly 
pronounced in stem cell research (Nisbet, 2004). Whilst these problems are 
central to all survey research, they become particularly important when survey 
data are used as evidence in policy debates.  
 
To summarise, therefore, the premise of a key UK policy document – that the 
majority of the British public supports embryonic stem cell research – appears to 
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be based on a specific rendering of a single question in a single opinion poll. In 
framing the question, and hence the legitimate focus of public concern, the poll 
as it is typically represented, constructs public opinion as being either for or 
against stem cell research. In so doing, however, it says little about the concerns 
that might be expressed about the way that research might be used. In our study, 
we addressed these latter concerns by exploring the issues and apprehensions 
raised by research participants themselves . Following lead from Wynne and 
others whose work has shown how framing of issue by lay citizens and other 
stakeholders may vary considerably, we began from the assumption that 
opinions may be complex, ambivalent and dependent on nuances of context and 
application (see e.g. Grove -White et al, 2000; Irwin, 2001). 
Talking treatments  – research design 
In our study, we tried to respond to these problems by enabling  groups of citizens 
to engage in a dialogue about stem cell research. The aim of the project was to 
organise and evaluate a public engagement process through which expert 
citizens (i.e. carers and patients) and lay citizens could contribute a deliberation 
about future treatment options for type 1 diabetes that also included a range of 
‘official experts’ such as scientists, clinicians and research funders. The methods 
used included expert interviews, reconvened focus -groups and a deliberative 
roundtable workshop.  
 
Unlike the survey, which requires quick answers to fixed questions, we wanted to 
give participants time to learn about and reflect on the issues before asking them 
to give their opinions. We also aimed to contextualise their debates: rather than 
staging a discussion about generalities, we selected a particular context (future 
treatments for diabetes) and attempted to mimic a real life decision-making 
process (rank ing the different options in terms of their funding priority). 
 
In this paper we will discuss the results of the focus group stage of the study. It 
comprised 7 reconvened focus groups, conducted in Cardiff during summer 2006 
(see the table 1): 
 
Table 1: Group composition 
group number participants gender age number of 
participants 
1 Lay men 28-57 5 
2 Lay women 33-51 3 
3 Lay women 23-35 3 
4 Carers mixed 21-46 5 
5 Carers mixed 23-48 5 
6 Patients mixed 21-50 5 
7 Patients mixed 45-67 4 
Total number of participants 30 
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Lay people (defined as those who have no training in, or specialist knowledge of, 
science, medicine or diabetes) were recruited through local schools and the 
University notice board. Recruitment of carers (people who have close friends or 
family members with type 1 diabetes) and patients was done mostly through the 
diabetes clinic – each patient with type 1 diabetes attending the clinic over two 
week period received a letter of invitation. Although we got a satisfactory 
response from the patients, this method was less effective for the recruitment of 
relatives and friends, who were mainly reached through the University notice 
board. For both patients and carers we wanted to reach people who were not 
actively involved in the patient advocacy movements or charity groups, hence we 
did not use diabetes charities, such as Diabetes UK or JDRF (Juvenile Diabetes 
Research Foundation), to recruit participants, although they did participate in 
other stages of the research.  
Procedures 
Each focus group met twice, with a two week gap between the two meetings. In 
the first group, participants were asked about their knowledge of diabetes and its 
treatments, their knowledge of stem cell research and other developments in the 
new genetics. They were then asked to fill in a ranking table with possible future 
therapeutic pathways, listed in Table 1, in rows and various evaluation criteria 
(e.g. ethics, risk, safety etc.) in columns. Initially, each participant filled in the 
table individually, interpreting each treatment and the criteria in their own way. In 
this way, we hoped to record of each participant’s individual opinions without 
peer pressure. The individual rankings were then put onto a single, integrated 
table so that all participants could see each other’s rankings. As we expected, the 
range of interpretations for the treatments and the ranking criteria varied 
significantly between participants at this stage. These differences and similarities 
were then discussed in the group. 
Table 2: Treatment Options used in Ranking Table  
improving existing treatment options (monitoring and medication) 
· finding non-invasive ways of blood glucose monitoring 
· producing better quality of insulin and working on better forms of delivery 
· developing drugs to treat diabetes and its complications  
technological solutions: 
· perfecting a closed-looped artificial pancreas 
regenerative medicine 
· perfecting islet transplantation 
· creating ‘universal donor’ sources of insulin through hESC research 
· immunological and preventative approaches 
· regenerating the body’s own beta cells without islet transplantation 
· preventing type 1 diabetes by maintaining or restoring immune tolerance. 
 
At the end of the first group meeting, participants received a range of information 
materials 8 relating to diabetes and each of the treatment options that had been 
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discussed. They were asked to read the material and complete the ranking table 
again before coming back in two weeks. At the second meeting, the participants 
compared their new ranking tables with their initial thoughts and with each 
others’.  
 
One of the main differences between our approach and other projects  was that 
stem cell research was discussed as one of several possible directions for the 
future treatment of diabetes and not the only option (unlike, for example, in 
Democs games).9 Participants were therefore asked to decide, using the ranking 
table as a guide, how the eight different therapeutic pathways listed should be 
prioritised.10 It is important to note that, when presented in this context, stem cell 
research, despite initial positive comments, was not ranked very highly by any of 
the groups.  
Results of the group discussions 
In this section we provide an overview of the participants’ opinions and 
evaluations of stem cell research and discuss some of the differences that 
emerged between various groups. We distinguish between the reasons given in 
support of stem cell research and  the arguments against prioritising it over other 
treatments, which were often voiced by the same people. Like others (e.g. Kerr 
and Franklin, 2006) we demonstrate that participants were ambivalent and 
illustrate the mixed views they had about stem cell research. This ambivalence, 
which was present at the first meetings, continued into the second focus group 
meeting where participants often reported that, although they had more 
confidence in their positions , they might change them later. Significantly, we also 
found that more information did not lead to more support and not necessarily 
even to more certainty. 
 
The other, more substantive, point to note is that, although the so-called ethical 
aspects of hESC research (e.g. the use of human embryos for research) are 
often presented as being the most controversial, most of our participants did not 
think this was particularly significant. To some extent this reflects the MORI 
survey quoted above , but where our research differs is that this absence of 
ethical concerns is not translated into a statement of support for hESC research. 
Instead, we identify a range of other concerns that led participants to prioritise 
different treatment options. All these views are examined in more detail below. 
Arguments in favour of stem cell research 
Participants in the focus groups were by no means opposed to hESC research. 
Many could make arguments for its support and most could see some benefit in 
pursuing it. Looking across the focus groups, the arguments these participants 
made in support of stem cell research can be grouped into three broad 
categories: 
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The first reason mirrors popular media discourses and emphasises the ‘huge’ 
medical potential of the research, which is seen as leading to cures for a number 
of diseases. The following extract is typical of this kind of argument: 
 
M: Right, why did you say it was promising? 
P5: From the hype, but from what I understand stem cells will grow you a 
new leg or a new heart or a new lung, or cure all these chronic conditions. 
(lay men group, initial meeting) 
 
The second set of arguments follow from this optimistic scenario, suggesting that 
hESC research is the only option for the future. In this account, the promise of 
hESC research represents  the only hope for millions of sufferers. 
 
P3: personally I think I would be for it, because I can’t see any other way 
forward really. It’s okay if you haven’t got those diseases, isn’t it, but if you 
want to eradicate them or move forward, I don’t know, if that’s what they 
are saying, this is the way forward . (lay women gr, 1, initial meeting) 
 
The final set of reasons continued this optimistic scenario, but tempered it with 
some caution. In taking this view, participants recognised ‘the hype’ surrounding 
stem cell research but understood that the potential benefits of stem cell research 
can never be realised without funding. The necessity of risky investment in 
medical technology was recognised in statements such as: 
 
P3: We will never know if the research is successful unless we put money 
into it. (carers gr2, initial meeting) 
 
In making these arguments, participants often referred to the limits of their own 
knowledge and the role of the media as a source of information about stem cell 
research. Nevertheless, that many participants had access to these discourses 
and, to some extent, believed them to be true, is important when interpreting their 
more cautious comments below. In particular, these were not people who were 
opposed to science in general or even stem cell research in particular. Almost all 
recognised it as a legitimate field of scientific research. What they could not do, 
however, was convince themselves that it was the most important.  
Views in opposition to stem cell research 
One unexpected finding was that participants did not mention the usual ethical 
challenges surrounding stem cell research when raising doubts about it. In part 
this was because many felt that, despite knowing stem cell research was ethically 
controversial, they could not explain what the source of these concerns was: 
 
P3: Most of what we hear about is the ethical side. And I don’t really know 
anything about it, but some people for some reason say it is possibly 
unethical but I’ve no idea why. (lay men group, initial meeting) 
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Significantly, even when the issues over the use of embryonic cells were clarified 
the consensus in all the groups was that these were not major concerns . Nearly 
all participants were prepared to accept the use of embryos for research 
providing this research fulfils its promise of finding cure for life threatening 
conditions. They did, however, raise two caveats to this position: 
 
1. using embryos for research when no definite guarantees about its 
outcome can be given is problematic, and  
2. ploughing resources into a field of research if many groups of citizens 
have serious objections to its ultimate application may be pointless. 
 
As the participants put it: 
 
P2: Mine isn't an opposing view as much on the ethical, moral side. I just 
don't know whether we're ever going to get to a consensus where we 
actually do agree to be able to do anything with them (hESCs). 
P1: I agree, it might happen that, as you say, they do lots of research but 
we never use. What’s the benefit of that?  
P2: I can see the benefit of it but I just don't know whether we're ever 
going to actually see those benefits.  (carers gr1, reconvened meeting) 
 
As noted above, the absence of a radical ethical objection to hESC research did 
not mean that participants backed stem cell research unreservedly. Instead, they 
identified a number of other concerns that prompted them to prioritise other 
options. Examples of these included: 
 
? Emotional investment in here and now: often manifested in the belief 
that time is running out for the sufferers who will die before any therapy is 
developed. Life is ‘now’ but stem cell science is too speculative to be 
presented as if it was on par with existing treatments. 
? Doubts about stem cell science: the recognition that stem cell science, 
even if it does lead to a therapy, may not offer a cure so that diabetes 
would be ‘managed’ rather than ‘eliminated’. There were also concerns 
about the problems of rejection, surgery, immunosuppressants and other 
potential side effects. 
? Irritation with the hype: the sense that there was a lot of noise but few, if 
any, results. Many were concerned that science and the media might be 
serving their own, vested, interests and that the complexity of stem cell 
science was being used to manipulate public opinion. 
 
Not all citizens used all these arguments, though most could appreciate most of 
them. In what follows we will elaborate on these views, focusing on comparison 
between lay citizens and the patients , as this does reveal an interesting 
difference of emphasis. 
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Lay Citizens 
Lay citizens represent the ordinary public and were expected to bring social 
judgement rather than specialist knowledge to their deliberations (Evans and 
Plows, 2007). To some extent this was borne out in the focus groups, where all 
participants said they had heard about stem cell research, but none were able to 
explain the details. The lay participants admitted that they did not have enough 
knowledge about stem cell research and that they relied on the mass media for 
most of their information. Their social judgement, also revealed in other studies 
(e.g. Kerr et al 1998), was exemplified in their comments about the validity of this 
information and their concern that the media were simply playing along with 
those who had a specific interest in promoting stem cell research: 
 
P1: I would take any claim of stem cell research at the moment with a very 
heavy pinch of salt.  The guys in the lab who are pursuing the research 
programmes or PhDs, the overall programmes, have to keep positive in 
terms of grant applications. 
P2: it is still very young technology in the area of research  
P1: Well, five years ago, a cloned human being of a stem cell was 
promised in five years time - that hasn’t happened. (lay men, initial 
meeting) 
 
Lay participants were thus often concerned with the likely return on investments 
in stem cell research. They often appeared rather irritated by the hype they felt 
surrounded research that had not yet shown much evidence of real 
achievements. In accounting for the press coverage, many were sceptical, 
suspecting that scientists and media were manipulating them into following a pre -
determined agenda. As one participant put it: 
 
‘the scientists may be very, very biased, wanting to grow this cell no 
matter what’. (lay women, gr1, initial meeting) 
 
Despite these concerns lay participants often struggled to define their own role in 
this debate. One finding of particular relevance for those concerned to promote 
public participation was that many of the lay participants explained (and justified) 
their lack of knowledge about stem cell research by saying that that they had no 
reason to be interested in it: ‘It doesn’t rock my boat’ – as one of them put it. 
Significantly, even when it came to the discussion of ethical issues, lay 
participants struggled to see their role in these debates as going beyond stating 
their own individual views:11 
 
P1: I would not be confident talking about the ethics of it – on others 
behalf. I have my own beliefs, I have very – I suppose I can make them 
black and white in my own head, but the idea of getting into the ethical 
acceptability for a population – no – straws in the wind – (…) – because 
there’s five people sat around this table, I’m sure therefore there will be six 
opinions minimum. (lay men, initial meeting) 
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Instead, perhaps not realising that this is also an ethical stance, most participants 
agreed that stem cell research and therapies should be a matter of personal 
choice for patients and donors. The donors should have a right to decide if their 
embryos or gametes are used for research, whilst patients should have the 
choice to accept or refuse treatments derived from embryonic stem cells . In 
neither case, should external ‘pro’ or ‘anti’ groups enforce their views on the 
others, even though the existence of these opposing views was also seen as 
problematic for the long-term development of stem cell research as neither side 
was likely to concede that the other was right. 
 
The effect of these concerns was that stem cell research was often seen as a 
relatively low priority, with the lay focus groups tending prioritise long-term 
investment in preventative and immunological type therapies that would address 
the underlying autoimmune condition (find the reasons for the destruction of ß-
cells) and potentially find ways to stop or prevent this from occurring. This in their 
view would constitute a proper cure for diabetes. Next in line were improvements 
to existing treatments, seen as a way of minimising problems until the ‘real’ cure 
was found. Creating ‘universal donor’ sources of insulin through hESC research 
and artificial pancreas approaches were typically at the bottom of the list, seen as 
complex, costly and uncertain ways of ameliorating the symptoms without 
actually addressing the underlying cause. 
Patients and Carers 
People whose lives were affected by diabetes voiced rather different, more 
practical, concerns to lay citizens. Rather than focusing on a cure that may be far 
away and involve other health risks they prioritised research that would improve  
their life in the near term. This typically manifested itself as a preference for 
technologies to improve control of blood glucose or the quality of insulin and 
other medication and thus to minimise the impact of diabetes on their life. 
 
Like the lay participants, they doubted the ability of stem cell research to bring 
about a treatment or cure in the foreseeable future, but in their case, the 
scepticism was based on more direct experience – personal expectations of 
medical interventions they had in the past and that have never materialised: 
 
P4: I've read and heard most of that (the promise of stem cell research). 
But my attitude over the years has been to sort of switch off to it because 
you know that it's not going to happen tomorrow and therefore you just 
think I'll wait until this actually becomes a bit more like reality.12 (patients 
gr 1, initial meeting) 
 
A second area of concern for all the patients who took part in focus groups was 
that a treatment for diabetes should not involve significant health risks. In 
particular, and this was something that became more important as they found out 
more about stem cell research, they did not want anything invasive. As a result, 
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and despite the claims that stem cell treatments might lead to a cure, patients 
were invariably cautious in their assessment:  
 
P3: Because it's invasive isn’t it. It's going to be … you're going to have to 
have some sort of procedure done to have the stem cells implanted into 
you. And take the drugs to prevent rejection. So it's obviously a more 
dangerous procedure than what I have now. (patients gr 1 , initial meeting) 
 
In making these judgements, patients readily admitted that they were acting 
‘selfishly’, by which they meant that they would prioritise research that would help 
them over research that might benefit some imaginable sufferers in the future. 
This not to say they were totally opposed to stem cell research. Rather, the 
general agreement was that stem cells cannot be considered as a priority for type 
1 diabetes because other conditions need this treatment more urgently and, in 
any case, it is possible to achieve reasonable quality of life through improving 
current treatments and diabetic care. 
 
P 5: And again, stem cell… I think it’s an absolutely fantastic thing that 
could happen, but I don’t, honestly, believe that diabetes is where it should 
all be geared to, initially. I think that should come in time but I don’t think 
that is a priority. Because we have a condition that is treatable: we can, 
actually, put our own destiny there. If we want to look after ourselves we’ll 
have a nice long healthy life. If we don’t want to bother then we’re going to 
have all the complications from it. Someone with Parkinson’s…not a lot 
you can do. (patients gr1 , reconvened meeting) 
 
Like lay citizens, therefore, patients and carers tended to favour the preventative 
and regenerating body’s own cells approaches over the hESC approach but, 
unlike the lay citizens, put improvements to existing therapies above either of 
these. 
Public Opinion as Questions not Answers 
The presumption of policy documents, including the Pattison Report, is that lay 
citizens and patients can participate in decision-making. If this is to happen, 
despite the reticence expressed by the lay participants in our research, it is 
necessary to understand what kinds of concerns they bring to the debate. If our 
criticism of survey research – i.e. that it reifies attitudes – is correct then we must 
also ask what a critical evaluation of our own methods suggests about the views 
of lay citizens and patients with respect to research priorities and their role in 
setting the research agenda. 
 
First, it is clear that both lay participants and the more expert patient and carer 
groups had complex views. All participants saw similar sets of positive arguments 
for stem cell research but these were offset by slightly differing sets of more 
negative concerns. Nevertheless, what was particularly noticeable was that, for 
all groups, the range of important concerns did not include the ethical issues 
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typically referred to in documents such as the Pattison Report. Rather 
participants had many different questions and concerns, which moderated the 
positive claims to a greater or lesser extent. As a consequence, participants did 
not consider their views as set in stone and were prepared to change them in 
light of the answers to their questions. This suggests that debates about policy 
and funding need to consider a broad range of issues and to interpret the 
opinions given as provisional rather than fixed. 
 
Treating public opinion in this way creates its own problems, however. For 
example, the potential effect of new information to act as a barrier to participation 
because people may feel they need more information before they can participate. 
In the case of stem cell research, the radical uncertainty created by the unknown 
future of the research meant that participants found it difficult to engage in the 
debates when, in their own words, they did not have enough knowledge about it. 
For example, our participants wanted to know how long it would take to produce 
hESC therapies and how much this would cost. They thus found themselves in a 
similar position with respect to stem cell research as the citizens described in 
Irwin et al’s study of a life near a chemical plant (Irwin et al., 1996). Both lay and 
patient participants were, on the one hand, suspicious of the vested interests 
various stakeholder groups had in promoting stem cell science and, on the other, 
believed that these same groups were best placed to provide definite answers to 
specific questions.  
 
One particularly striking manifestation of this expectation of certainty was the way 
scientific expertise was discussed. In general, participants did not see technical 
limits or problems as a constraint on hESC research. Instead, almost all 
participants thought that anything was possible and believed that scientists could 
differentiate hESCs into everything if only they had enough time and money. 
Perhaps more surprisingly, this trust in science also extended to its related 
institutions. Noticeable by its absence from the discussion was any strong 
concern about the risks that hESC therapies might pose either to patients or 
public health. This meant that, although participants identified a range of 
concerns, these did not include the issues that social scientists typically raise. 
Thus, for example, concerns about social justice and equity were not mentioned. 
In the case of patient groups, even though they shared rich personal knowledge 
about the lack of resources in Primary Care Trusts and the difficulty of accessing 
the currently available treatments they did not consider the effect of stem cell 
therapies on the resources available for other treatments .13  
 
In summary, then, our research confirmed many of the findings of other 
qualitative studies, in that it revealed the dangers of reifying public opinions  
(Cunningham-Burley, et al., 2001, Dolan et. al., 1999, Fisher, 1999). In our study 
participants expressed a range of views and concerns, depending on the specific 
context and in response to new information. As well as being prone to change, 
these opinions were presented as narratives rather than a single, fixed answer. 
Rather than seeing this as problematic, however, we would argue that these 
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narratives reveal the very ambivalences and contradictions that participants 
struggled with when asked to have a definite say and which participation 
processes should allow them to express. Although they did not voice all the 
questions that could be asked, and perhaps not even the ones that we expected 
from them, they did nevertheless express the concerns that were salient to them. 
Conclusions 
The central claim of this paper has been that the standard survey-based 
representation of public opinion that dominates UK policy documents is 
misleading. Not only does it convey a false sense of certainty about that opinion, 
it fails to articulate the concerns people do express when given the space to se t 
their own agenda. These concerns matter because, if a meaningful public 
engagement with hESC and other nascent scientific fields is to take place, then 
such a process needs to start from the actors’ categories and not the framing 
preferred by the scientific elite. 
 
What our research shows is that starting from the lay citizens does not lead 
inevitably to opposition. Rather, what it demonstrates is a concern to strike the 
appropriate balance between competing claims and concerns. The quotes below 
illustrate how one participant in our stud y reflected both on what she thinks and 
how and why she thinks as she does. Like many others, she felt that she did not 
have enough knowledge to have an opinion: 
 
P2: I mean I know it’s [hESC research] controversial and I know that 
people perceive it as being controversial and that your … you know, you’d 
be making a fundamental change to something that is … is a certain way. 
So I know that … but, as a personal opinion, I don’t really have a strong 
personal opinion because I think I’d need to know more about it to have 
one. (carers gr1 , initial meeting) 
  
In explaining this, she describes herself as being torn between a personal 
preference and the idea of more general moral position: 
 
P2: That’s where I have like two sides of me that’ll sort of argue with each 
other, that there’s a side of me that says: personally, people I know have 
gone through real horrible things; if you can stop that then that would be 
fantastic. But then the other half of me, you know, can see where you’re 
coming from and I think: is this morally right? And I really struggle with it. I 
really do. (carers gr1, initial meeting) 
 
Significantly for those who still hold the deficit model and hope that explaining 
more about the science will solve the problem, the information materials provided 
about stem cell and other treatments, did not help this person to end their inner 
conflict:  
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P2: (…) I still… even with reading everything, I still found myself in a real 
sort of like what do I think. (…) I just think are we going to get hung up on 
deciding that this is the way we want to move forward when we could be 
investing things on other things that we've got the green light on now. And 
are we… you know, so I just found myself in even more of a quandary that 
I was before by the time I'd read and watched everything. (carers gr 1, 
reconvened meeting) 
 
The key issue for public participation is to know what to make of such 
ambivalence. The crucial step, recognised in other studies, and made explicit in 
our research is that it should not be concealed, eliminated or dismissed. Rather, 
if stem cell research really is seen as complex and controversial, then 
ambivalence may be a more accurate reflection of what people think than 
aggregate findings that a particular proportion of the public does or does not 
support stem cell research. Framing the statement in this way reinforces 
polarisation – the very thing that participants were worried about. Moreover, 
presenting public opinion as blocks of undifferentiated support or opposition may 
be harmful in the long run as it misrepresents the variety of views held by 
different publics. If this is correct then, rather than being taken by the simplified 
representations about public opinion, policy makers should be open towards 
more genuine understanding of diversity, ambivalence and uncertainty of public 
views.  
 
There is also a more positive conclusion that can be drawn from this. To the 
extent that this ambivalence of the wider society is an accurate reflection of the 
uncertainty within the scientific community, then it must be a legitimate input into 
the regulation and governance of science for setting the priorities for future 
research. This is not to say that citizens should decide when a scientific claim 
has or has not been falsified, but that the hopes and concerns of lay citizens and 
patient groups are important and should be encouraged at much earlier stages of 
the scientific and policy process. In particular, giving greater emphasis to such 
unstructured public dialogue at an early stage in the development of new 
research fields like stem cell research and nanoscience allows both funders and 
scientists a greater insight in the needs of those they claim to serve  (Macnaghten 
et al, 2005). In the case of treatments for diabetes and the role of stem cell 
research in their future development, both patients and lay citizens currently 
prefer a future that is rather different to the one envisaged by the scientists and 
funders.  
 
Finally, we should be clear in saying that identifying the different priorities 
accorded to stem cell research by scientific and other communities does not 
imply that lay citizens or patient groups should have a veto on scientific research. 
Rather, it calls for a reconfiguration of the relationship between science and the 
wider society and the context within which scientific research takes place (cf. 
Wilsdon and Willis, 2004). Rather than being presumed autonomous, whilst in 
practice tied to a particular world view, promoting upstream public engagement 
Qualiti Working Papers: Public Opinion as questions not answers: how citizens evaluate the therapeutic 
potential of stem cell research in the context of T1 diabetes  
March 2007 16 
promotes a debate about the purposes that science should serve. In this way, 
public opinion becomes the mechanism through which society poses new 
questions to science rather giving its verdict on their answers. 
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1 Pattison report, UK Stem cell initiative. Report&recommendations. November 2005. 
(available to download from http://www.advisorybodies.doh.gov.uk/uksci/index.htm) 
2 Although some authors demonstrated that broadening public participation have only 
limited value in improving public confidence in the regulatory regime as many other 
factors inhibit this outcome (see Rothstein, 2004). Irwin (2006) argued that that 
openness might create further grounds for criticism and concern.  
3 In our research project we investigated public perceptions of the risks and benefits of 
innovative medical treatments for type 1 diabetes, including islet transplantation, 
various mechanisms of insulin delivery, vaccination, and regenerative medicine. 
4 For example Citizens Jury by Techniquest in Cardiff, a series of Democs games across 
the country, HEFA consultation as well as academic studies, e.g. by Sarah Parry’s 
project The -Social-Dynamics-of-Public-Engagement-in-Stem-Cell-Research 
(http://www.innogen.ac.uk/Research/). 
5 It is questionable to which extent government makes use of public opinion polls if they 
contradict what government wants to hear. In 2004, a Harris poll suggested that nearly 
three quarters of Americans support stem cell research. This number increased from a 
similar poll in 2001.  
6 Online at http://www.mori.com/polls/2003/amrc.shtml 
7 YouGov online survey: It's called Abortion, Euthanasia and Cloning, 30/8/2005 
Available online www.yougov.com/archives/pdf/TEL050101042_1.pdf 
A survey of the UK public's attitudes to current ethical and moral issues has indicated 
there is support for reducing the legal time limit for abortions. 
8 Information materials consisted of 1) main booklet, where the information about 
diabetes, current treatments and each of the potential treatment options was described 
in an accessible format; 2) complementary materials – these included more detailed 
information about each of the new treatment options. This information was collated 
from various sources to represent the range of opinions and kinds of discourses on each 
topic: scientific articles, media reports, Q&A sections from charity websites, articles 
from diabetes journals (Balance); 3) a DVD – A Stem Cell story produced for public use 
by EuroStem Cell. 
9 Democs, which stands for 'DEliberative Meeting Of Citizens', was developed by The 
New Economic Foundation (NEF), with the support of the Wellcome Trust. Democs is 
part card game, part policy-making tool and enables small groups of people to engage 
with complex public policy issues. It has been recently adapted to discuss stem cell 
research and applied across the country. For more information go to: 
http://www.neweconomics.org/gen/democs.aspx [accessed 1 February 2007] 
10 We must emphasise that we did not want to use ranking table as a data-generation 
tool, e.g. by treating the rankings as serious ordinal data. Instead, the table was a tool 
for facilitating discussion and making explicit the opportunity cost of choosing to 
prioritise one treatment rather than another. The data thus comprised the discussions 
about participants choices and the explanations they gave for these . 
11 When asked who should be involved in the ethical debates, they often named 
religious groups or ‘professors of ethics or professors of philosophy, doctors as well, 
scientists a big group need to really look at the ethics of it’ (lay women, gr 1 meeting 1).  
There was some inconsistency, however. Participants generally thought that it was 
desirable to have lay people on these committees to represent the ‘ordinary public’. 
Nevertheless, when asked to do this, they typically felt unable or unwilling to fulfil this 
role and found it very uncomfortable to speak for the collective or for others. More 
generally, we found that participants found ‘ethical criteria’ particularly difficult to 
interpret or operationalise, with the result that several participants declined giving any 
‘ethical’ ranking. 
12 The difference between the lay and patient groups thus maps neatly on to the 
distinction between ‘ubiquitous’ and ‘local’ discrimination described by Collins and 
Evans (2002, 2007) 
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13 Similarly, despite a number of recent stories about the availability of drugs such as 
herceptin, none of the lay groups raised the question of whether or not the opportunity 
cost of stem cell research and treatments would be acceptable. 
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